Mashup Score: 2
HealioWASHINGTON — In the ADAPT-TAVR trial of patients who had transcatheter aortic valve replacement and no indication for long-term anticoagulation, edoxaban did not improve
See more from Cardiology Today
ICYMI: “The overall incidence of leaflet thrombosis on CT scan was less frequent with edoxaban therapy compared with DAPT therapy, although it did not reach statistical significance,” @dukwoo_park @ACCinTouch #ACC22 #Cardiotwitter https://t.co/ViVMANPdTb - view on twitter